Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Periocular corticosteroid injections in uveitis: effects and complications.

Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH.

Ophthalmology. 2014 Nov;121(11):2275-86. doi: 10.1016/j.ophtha.2014.05.021. Epub 2014 Jul 11.

2.

Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.

Leder HA, Jabs DA, Galor A, Dunn JP, Thorne JE.

Am J Ophthalmol. 2011 Sep;152(3):441-448.e2. doi: 10.1016/j.ajo.2011.02.009. Epub 2011 Jun 8.

PMID:
21652023
3.

Outcome of intravitreal triamcinolone in uveitis.

Kok H, Lau C, Maycock N, McCluskey P, Lightman S.

Ophthalmology. 2005 Nov;112(11):1916.e1-7. Epub 2005 Sep 19.

PMID:
16171868
4.

Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis.

Salek SS, Leder HA, Butler NJ, Gan TJ, Dunn JP, Thorne JE.

Ocul Immunol Inflamm. 2013 Aug;21(4):257-63. doi: 10.3109/09273948.2013.767353. Epub 2013 Apr 25.

PMID:
23617776
5.

Periocular corticosteroid injection in the management of uveitis in children.

Habot-Wilner Z, Sallam A, Roufas A, Kabasele PM, Grigg JR, McCluskey P, Lightman S.

Acta Ophthalmol. 2010 Dec;88(8):e299-304. doi: 10.1111/j.1755-3768.2010.02025.x.

6.

Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.

Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS.

Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):205-12.

PMID:
16019680
7.

Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.

Gregory AC 2nd, Kempen JH, Daniel E, Kaçmaz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group.

Ophthalmology. 2013 Jan;120(1):186-92. doi: 10.1016/j.ophtha.2012.07.052. Epub 2012 Oct 11.

8.

Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.

Chieh JJ, Carlson AN, Jaffe GJ.

Am J Ophthalmol. 2008 Oct;146(4):589-594. doi: 10.1016/j.ajo.2008.05.035. Epub 2008 Jul 17.

PMID:
18639220
9.
10.

Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.

Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T; Fluocinolone Acetonide Uveitis Study Group.

Ophthalmology. 2006 Jun;113(6):1020-7. Epub 2006 May 9.

PMID:
16690128
11.

Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.

Okhravi N, Morris A, Kok HS, Menezo V, Dowler JG, Hykin PG, Lightman S.

J Cataract Refract Surg. 2007 Jul;33(7):1278-83.

PMID:
17586387
12.

Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.

Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL.

Ophthalmology. 2009 Apr;116(4):797-801. doi: 10.1016/j.ophtha.2008.10.033.

PMID:
19344827
13.

[Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].

Bleriot A, Couret C, Le Meur G, Lebranchu P, Weber M.

J Fr Ophtalmol. 2014 Oct;37(8):599-604. doi: 10.1016/j.jfo.2014.04.010. Epub 2014 Sep 8. French.

14.

Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.

Sallam A, Sheth HG, Habot-Wilner Z, Lightman S.

Am J Ophthalmol. 2009 Aug;148(2):207-213.e1. doi: 10.1016/j.ajo.2009.02.032. Epub 2009 Apr 29.

PMID:
19403113
15.

Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.

Parekh A, Srivastava S, Bena J, Albini T, Nguyen QD, Goldstein DA.

JAMA Ophthalmol. 2015 May;133(5):568-73. doi: 10.1001/jamaophthalmol.2015.51.

PMID:
25719937
16.

Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.

Jaffe GJ, Ben-Nun J, Guo H, Dunn JP, Ashton P.

Ophthalmology. 2000 Nov;107(11):2024-33.

PMID:
11054326
17.
18.

Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis.

Hogewind BF, Zijlstra C, Klevering BJ, Hoyng CB.

Eur J Ophthalmol. 2008 May-Jun;18(3):429-34.

PMID:
18465727
19.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

Cekiç O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
20.

[Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis].

Bui Quoc E, Bodaghi B, Adam R, Burtin T, Cassoux N, Dreifuss S, Fardeau C, LeHoang P.

J Fr Ophtalmol. 2002 Dec;25(10):1048-56. French.

Items per page

Supplemental Content

Write to the Help Desk